Topic: Vaccine Research

The hosts discuss the potential use of Ivermectin for Hantavirus, noting it is an RNA virus. Dr. Scott Gottlieb dismissed the treatment on television, arguing the drug's mechanism does not work against this specific virus, while the hosts point out that 15 different Hantavirus vaccines are currently in development by various military and health agencies.

The National Institutes of Health has canceled dozens of research grants focused on vaccine hesitancy, stating they no longer align with the administration's priorities. Researchers, including Dr. Sophia Newcomer, argue that their work was intended to improve healthcare access for rural families rather than just studying parental reluctance.

The FBI and federal cybersecurity agents warned that hackers linked to the Chinese and Iranian governments were targeting U.S. universities and pharmaceutical companies to steal COVID-19 research. Assistant Attorney General John Demers stated that China is desperate to be the first to develop a vaccine for geopolitical prestige. Tensions escalated as President Trump suggested reporters "ask China" about the global death toll during a press briefing.

Washington Post columnist Jennifer Rubin, often billed as a conservative, is criticized for her "communist" leanings and her advice to Democrats. Rubin suggested that the party needs to use "pithy" messaging, such as claiming "Republicans want to kill your kids" by opposing vaccines and semi-automatic weapon bans. The hosts view this as an example of the extreme rhetoric contributing to political burnout.

A Bloomberg interview with an independent journalist regarding the situation at Chernobyl is mocked for its lack of substance. A controversial study from ECOS Research in Canada claims a high correlation between being vaccinated against COVID-19 and supporting harsh measures against Russia. While initially skeptical, the hosts find data tables suggesting the study is real, implying that "unvaccinated" individuals are being framed as Russian sympathizers.

A university research director provides a debunking of the "graphene oxide in vaccines" theory. The researcher explains that the graphene oxide seen in viral lab reports actually came from the grids used in transmission electron microscopy, not the vaccine samples themselves. The hosts accept this explanation while maintaining that vaccines may still contain other manufacturing debris.

The discussion revisits claims by a Nobel Prize-winning French scientist regarding HIV-like gene sequences found in the COVID-19 virus. The hosts speculate that researchers may have been using the virus as a vector for HIV vaccine development, a topic they note has largely disappeared from mainstream media coverage.

The Texas Center for Drug Development and DM Clinical Research are recruiting a diverse pool of volunteers in Houston for COVID-19 vaccine trials. Participants in these Phase 2 and Phase 3 trials are offered a minimum of $1,000 to test the safety and efficacy of investigational vaccines. The recruitment campaign specifically targets young people and diverse populations to ensure the vaccine is effective across all demographics.

The FBI and federal cybersecurity agents issued a warning that hackers linked to the Chinese government are attempting to steal U.S. research on COVID-19 vaccines and treatments. Iran is also accused of targeting executives at Gilead Sciences, the maker of Remdesivir. The hosts also comment on the vocal condition of CBS correspondent Jeff Pegues during his reporting.

Jess McIntosh of Emily's List defends Planned Parenthood, arguing that the undercover videos are dishonestly edited. She emphasizes the medical necessity of fetal tissue donation for researching cures for Alzheimer's and Parkinson's. McIntosh claims that such tissue was instrumental in developing the rabies, chicken pox, and polio vaccines.

A report in National Geographic explores the "disconnect" between scientific consensus and public belief on issues like GMO safety, vaccines, and climate change. Pew Research data shows significant gaps, such as 88% of scientists supporting GMO safety compared to only 37% of the public. The segment also mentions a fringe theory regarding a series of mysterious deaths among doctors and AIDS researchers, including the inventor of the HPV vaccine.

The Obama administration is considering guidelines for testing the anthrax vaccine on children to prepare for potential bioterrorist attacks. While over one million U.S. service members have received the vaccine, its effects on children remain unknown. A federal panel led by Dr. Daniel Fagbuyi is exploring the ethics of these tests, despite the vaccine being considered "extremely dangerous."

A bipartisan WMD Research Center report card issued failing grades for U.S. preparedness against biological attacks. The media coverage transitioned from discussing the seasonal flu to the threat of anthrax and weapons of mass destruction. The hosts suggest this narrative shift is intended to secure government funding and promote newer, faster vaccine production methods.

Reports of a "breakthrough" universal flu vaccine that could protect against all strains are met with skepticism. The hosts argue that the pharmaceutical industry prefers the current model of selling seasonal vaccines annually. They predict that a universal vaccine will likely be suppressed or found to have significant side effects because it would eliminate a major "cash cow" for drug companies.

The debate between Shepard Smith and a healthcare worker continues regarding the safety of fast-tracked H1N1 vaccines containing thimerosal. Smith argues that it is irresponsible for healthcare workers to discourage viewers from following CDC advice without conducting their own formal research. The hosts interpret Smith's aggressive stance as a "dick ending" intended to shut down legitimate dissent against government mandates.

Researchers have identified human antibodies that may neutralize multiple strains of influenza, including H5N1 bird flu. By targeting a non-mutating part of the virus, scientists hope to develop a universal vaccine that could eventually eradicate the flu. This discovery represents a significant shift from traditional vaccines that must be reformulated annually.